{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:55:25Z","timestamp":1792612525817,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s12020-014-0200-7","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T10:51:26Z","timestamp":1398077486000},"page":"631-638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome"],"prefix":"10.1007","volume":"47","author":[{"given":"Sarantis","family":"Livadas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Karachalios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Marinakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoleta","family":"Tolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Drakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippos","family":"Kaldrymides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Panidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Diamanti-Kandarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,22]]},"reference":[{"key":"200_CR1","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/S1462399408000598","volume":"3010","author":"E Diamanti-Kandarakis","year":"2008","unstructured":"E. Diamanti-Kandarakis, Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev. Mol. Med. 3010, e3 (2008)","journal-title":"Expert Rev. Mol. Med."},{"key":"200_CR2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"E. Diamanti-Kandarakis, A. Dunaif, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33, 981\u20131030 (2012)","journal-title":"Endocr. Rev."},{"key":"200_CR3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1590\/S0004-27302009000200014","volume":"53","author":"E Kandaraki","year":"2009","unstructured":"E. Kandaraki, C. Christakou, E. Diamanti-Kandarakis, Metabolic syndrome and polycystic ovary syndrome\u2026 and vice versa. Arq. Bras. Endocrinol. Metabol. 53, 227\u2013237 (2009)","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"200_CR4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.2007.02954.x","volume":"67","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"E. Diamanti-Kandarakis, D. Panidis, Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin. Endocrinol. (Oxf.) 67, 735\u2013742 (2007)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"200_CR5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/138161212799040457","volume":"18","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"E. Diamanti-Kandarakis, C. Christakou, E. Marinakis, Phenotypes and environmental factors: their influence in PCOS. Curr. Pharm. Des. 18, 270\u2013282 (2012)","journal-title":"Curr. Pharm. Des."},{"key":"200_CR6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12020-012-9701-4","volume":"42","author":"SF Witchel","year":"2012","unstructured":"S.F. Witchel, S.E. Recabarren, F. Gonz\u00e1lez, E. Diamanti-Kandarakis, K.I. Cheang, A.J. Duleba, R.S. Legro, R. Homburg, R. Pasquali, R.A. Lobo, C.C. Zouboulis, F. Kelestimur, F. Fruzzetti, W. Futterweit, R.J. Norman, D.H. Abbott, Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine 42, 526\u2013534 (2012)","journal-title":"Endocrine"},{"key":"200_CR7","first-page":"19","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). Fertil. Steril. 81, 19\u201325 (2004)","journal-title":"Fertil. Steril."},{"key":"200_CR8","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1210\/jc.2007-2656","volume":"93","author":"MA Lawson","year":"2008","unstructured":"M.A. Lawson, S. Jain, S. Sun, K. Patel, P.J. Malcolm, R.J. Chang, Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women. J. Clin. Endocrinol. Metab. 93, 2089\u20132096 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"200_CR9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0015-0282(16)55797-5","volume":"59","author":"TD Pache","year":"1993","unstructured":"T.D. Pache, F.H. de Jong, W.C. Hop, B.C. Fauser, Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertil. Steril. 59, 544\u2013549 (1993)","journal-title":"Fertil. Steril."},{"key":"200_CR10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/humrep\/13.6.1437","volume":"13","author":"AA Kyei-Mensah","year":"1998","unstructured":"A.A. Kyei-Mensah, S. LinTan, J. Zaidi, H.S. Jacobs, Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome. Hum. Reprod. 13, 1437\u20131441 (1998)","journal-title":"Hum. Reprod."},{"key":"200_CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/09513599109028438","volume":"5","author":"Z Puziga\u0107a","year":"1991","unstructured":"Z. Puziga\u0107a, G.M. Prelevi\u0107, Z. Stretenovi\u0107, L. Balint-Peri\u0107, Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome. Gynecol. Endocrinol. 5, 167\u2013174 (1991)","journal-title":"Gynecol. Endocrinol."},{"key":"200_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/EJE-10-0692","volume":"164","author":"R Pasquali","year":"2011","unstructured":"R. Pasquali, A. Gambineri, C. Cavazza, D. Ibarra Gasparini, W. Ciampaglia, G.E. Cognigni, U. Pagotto, Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome. Eur. J. Endocrinol. 164, 53\u201360 (2011)","journal-title":"Eur. J. Endocrinol."},{"key":"200_CR13","first-page":"139","volume":"85","author":"P Moghetti","year":"2000","unstructured":"P. Moghetti, R. Castello, C. Negri, F. Tosi, F. Perrone, M. Caputo, E. Zanolin, M. Muggeo, Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo controlled 6-month trial, followed by open long-term. J. Clin. Endocrinol. Metab. 85, 139\u2013146 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"200_CR14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/09513590.2011.650770","volume":"28","author":"N K\u00f6\u015f\u00fc\u015f","year":"2012","unstructured":"N. K\u00f6\u015f\u00fc\u015f, A. K\u00f6\u015f\u00fc\u015f, Z. Kamalak, D. H\u0131zl\u0131, N.\u00d6. Turhan, Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome. Gynecol. Endocrinol. 28, 611\u2013614 (2012)","journal-title":"Gynecol. Endocrinol."},{"key":"200_CR15","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.fertnstert.2008.02.101","volume":"91","author":"K Brennan","year":"2009","unstructured":"K. Brennan, A. Huang, R. Azziz, Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome. Fertil. Steril. 91, 1848\u20131852 (2009)","journal-title":"Fertil. Steril."},{"key":"200_CR16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1530\/eje.1.02153","volume":"154","author":"A Dagre","year":"2006","unstructured":"A. Dagre, J. Lekakis, C. Mihas, A. Protogerou, L. Thalassinou, D. Tryfonopoulos, G. Douridas, C. Papamichael, M. Alevizaki, Association of dehydroepiandrosterone-sulfate with endothelial function in young women with polycystic ovary syndrome. Eur. J. Endocrinol. 154, 883\u2013890 (2006)","journal-title":"Eur. J. Endocrinol."},{"key":"200_CR17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s12020-013-9971-5","volume":"44","author":"D Panidis","year":"2013","unstructured":"D. Panidis, K. Tziomalos, E. Papadakis, C. Vosnakis, P. Chatzis, I. Katsikis, Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility. Endocrine 44, 583\u2013590 (2013)","journal-title":"Endocrine"},{"key":"200_CR18","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.fertnstert.2008.12.138","volume":"93","author":"A Huang","year":"2010","unstructured":"A. Huang, K. Brennan, R. Azziz, Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the NIH 1990 criteria. Fertil. Steril. 93, 1938\u20131941 (2010)","journal-title":"Fertil. Steril."},{"key":"200_CR19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"9","author":"R Azziz","year":"2009","unstructured":"R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, W. Futterweit, O.E. Janssen, R.S. Legro, R.J. Norman, A.E. Taylor, S.F. Witchel, Task force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS Society. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. Fertil. Steril. 9, 456\u2013488 (2009)","journal-title":"Fertil. Steril."},{"key":"200_CR20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1477-7827-10-96","volume":"10","author":"L Gabrielli","year":"2012","unstructured":"L. Gabrielli, E.M. Aquino, Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare. Reprod. Biol. Endocrinol. 10, 96 (2012)","journal-title":"Reprod. Biol. Endocrinol."},{"key":"200_CR21","first-page":"198","volume":"3","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"E. Diamanti-Kandarakis, J. Papailiou, S. Palimeri, Hyperandrogenemia: pathophysiology and its role in ovulatory dysfunction in PCOS. Pediatr. Endocrinol. Rev. 3, 198\u2013204 (2006)","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"200_CR22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dml017","volume":"12","author":"SK Blank","year":"2006","unstructured":"S.K. Blank, C.R. McCartney, J.C. Marshall, The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum. Reprod. Update 12, 351\u2013361 (2006)","journal-title":"Hum. Reprod. Update"},{"key":"200_CR23","first-page":"2248","volume":"82","author":"AE Taylor","year":"1997","unstructured":"A.E. Taylor, B. McCourt, K.A. Martin, E.J. Anderson, J.M. Adams, D. Schoenfeld, J.E. Hall, Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 82, 2248\u20132256 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"200_CR24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.steroids.2011.12.007","volume":"77","author":"CM Solorzano","year":"2012","unstructured":"C.M. Solorzano, J.P. Beller, M.Y. Abshire, J.S. Collins, C.R. McCartney, J.C. Marshall, Neuroendocrine dysfunction in polycystic ovary syndrome. Steroids 77, 332\u2013337 (2012)","journal-title":"Steroids"},{"key":"200_CR25","first-page":"1318","volume":"86","author":"AJ Jakimiuk","year":"2001","unstructured":"A.J. Jakimiuk, S.R. Weitsman, A. Navab, D.A. Magoffin, Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J. Clin. Endocrinol. Metab. 86, 1318\u20131323 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"200_CR26","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","volume":"13","author":"VL Nelson","year":"1999","unstructured":"V.L. Nelson, R.S. Legro, J.M. McAllister, Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol. Endocrinol. 13, 946\u2013957 (1999)","journal-title":"Mol. Endocrinol."},{"key":"200_CR27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2010.08.088","volume":"1364","author":"RL Rosenfield","year":"2010","unstructured":"R.L. Rosenfield, B. Bordini, Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity. Brain Res. 1364, 186\u2013197 (2010)","journal-title":"Brain Res."},{"key":"200_CR28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0960-0760(92)90081-S","volume":"43","author":"V Toscano","year":"1992","unstructured":"V. Toscano, R. Balducci, P. Bianchi, R. Guglielmi, A. Mangiantini, F. Sciarra, Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation. J. Steroid Biochem. Mol. Biol. 43, 431\u2013437 (1992)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"200_CR29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.1988.tb48867.x","volume":"538","author":"MG Forest","year":"1988","unstructured":"M.G. Forest, A. Lecoq, M. David, M. Pugeat, Effects of human chorionic gonadotropin, androgens, adrenocorticotropin hormone, dexamethasone and hyperprolactinemia on plasma sex steroid-binding protein. Ann. N. Y. Acad. Sci. 538, 214\u2013234 (1988)","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"200_CR30","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s12020-012-9728-6","volume":"42","author":"F Gonz\u00e1lez","year":"2012","unstructured":"F. Gonz\u00e1lez, C.L. Sia, F.Z. Stanczyk, H.E. Blair, M.E. Krupa, Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome. Endocrine 42, 726\u2013735 (2012)","journal-title":"Endocrine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0200-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-014-0200-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0200-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:56:50Z","timestamp":1559440610000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-014-0200-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,22]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["200"],"URL":"https:\/\/doi.org\/10.1007\/s12020-014-0200-7","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,22]]}}}